Your browser is no longer supported. Please, upgrade your browser.
Codexis, Inc.
Index- P/E- EPS (ttm)-0.24 Insider Own2.30% Shs Outstand64.63M Perf Week-17.65%
Market Cap1.35B Forward P/E- EPS next Y-0.53 Insider Trans-11.46% Shs Float63.22M Perf Month-35.11%
Income-15.00M PEG- EPS next Q-0.22 Inst Own97.70% Short Float14.41% Perf Quarter-31.00%
Sales101.30M P/S13.32 EPS this Y-91.60% Inst Trans-2.09% Short Ratio12.41 Perf Half Y-5.35%
Book/sh2.62 P/B7.57 EPS next Y-39.50% ROA-6.90% Target Price39.38 Perf Year-23.61%
Cash/sh1.75 P/C11.32 EPS next 5Y15.00% ROE-9.00% 52W Range16.55 - 42.01 Perf YTD-36.58%
Dividend- P/FCF- EPS past 5Y-16.00% ROI-14.30% 52W High-52.80% Beta1.70
Dividend %- Quick Ratio5.20 Sales past 5Y10.60% Gross Margin79.00% 52W Low19.82% ATR1.81
Employees181 Current Ratio5.20 Sales Q/Q100.00% Oper. Margin-16.00% RSI (14)21.52 Volatility6.56% 6.52%
OptionableYes Debt/Eq0.00 EPS Q/Q132.10% Profit Margin-14.80% Rel Volume1.06 Prev Close20.79
ShortableYes LT Debt/Eq0.00 EarningsNov 04 AMC Payout- Avg Volume734.42K Price19.83
Recom1.60 SMA20-28.46% SMA50-37.57% SMA200-23.95% Volume782,031 Change-4.62%
Apr-12-21Initiated Piper Sandler Overweight $32
Mar-01-21Initiated Stifel Buy $30
Feb-26-21Reiterated H.C. Wainwright Buy $21 → $26
Mar-10-20Initiated The Benchmark Company Buy
Jan-17-19Upgrade First Analysis Sec Neutral → Outperform $12 → $19
May-16-18Initiated Stephens Overweight $16
Oct-13-17Reiterated H.C. Wainwright Buy $8 → $8.50
May-31-17Initiated Jefferies Buy $8
Jan-26-17Downgrade First Analysis Sec Overweight → Equal-Weight $5.50
Jan-04-17Upgrade Ladenburg Thalmann Neutral → Buy
Jan-06-16Initiated H.C. Wainwright Buy $6
Jan-12-22 11:25AM  
Jan-11-22 12:00PM  
Jan-05-22 08:00AM  
Jan-04-22 04:43AM  
Dec-24-21 09:34AM  
Dec-15-21 08:00AM  
Nov-22-21 08:00AM  
Nov-19-21 08:00AM  
Nov-15-21 08:00AM  
Nov-09-21 04:05PM  
Nov-06-21 09:03AM  
Nov-05-21 04:01AM  
Nov-04-21 08:56PM  
Nov-03-21 04:05PM  
Oct-28-21 03:05PM  
Oct-21-21 04:05PM  
Oct-20-21 07:35AM  
Oct-18-21 12:26PM  
Oct-14-21 08:50AM  
Oct-04-21 09:07AM  
Sep-10-21 07:43AM  
Sep-09-21 04:05PM  
Sep-07-21 04:05PM  
Aug-25-21 04:05PM  
Aug-10-21 09:11AM  
Aug-08-21 03:13AM  
Aug-05-21 08:05PM  
Aug-02-21 08:00AM  
Jul-26-21 04:05PM  
Jul-22-21 04:05PM  
Jul-14-21 04:05PM  
Jul-07-21 04:05PM  
Jun-28-21 02:41AM  
Jun-21-21 12:56AM  
Jun-18-21 07:13AM  
Jun-17-21 04:44PM  
Jun-10-21 07:00AM  
May-26-21 10:53AM  
May-25-21 04:05PM  
May-17-21 04:05PM  
May-06-21 06:20PM  
Apr-22-21 04:05PM  
Apr-05-21 03:10PM  
Mar-30-21 02:51AM  
Mar-01-21 10:14AM  
Feb-25-21 04:55PM  
Feb-18-21 04:05PM  
Feb-16-21 05:59AM  
Feb-13-21 02:19AM  
Feb-11-21 04:05PM  
Feb-09-21 04:05PM  
Feb-03-21 04:05PM  
Jan-13-21 07:00AM  
Jan-08-21 12:55AM  
Jan-05-21 07:00AM  
Dec-31-20 07:31PM  
Dec-30-20 02:50PM  
Dec-14-20 11:39AM  
Dec-08-20 12:44AM  
Dec-02-20 11:11PM  
Nov-24-20 05:02PM  
Nov-09-20 07:00AM  
Nov-07-20 08:38AM  
Nov-05-20 08:30PM  
Oct-29-20 07:00AM  
Sep-08-20 07:00AM  
Aug-11-20 08:33AM  
Aug-06-20 04:05PM  
Jul-30-20 07:00AM  
Jul-28-20 12:33PM  
Jun-23-20 07:00AM  
Jun-22-20 03:06PM  
Jun-16-20 04:05PM  
Jun-14-20 03:50PM  
Jun-01-20 04:05PM  
May-27-20 07:00AM  
May-22-20 07:31PM  
May-11-20 07:00AM  
May-09-20 01:30AM  
May-07-20 04:05PM  
May-06-20 04:05PM  
May-05-20 07:00AM  
Apr-30-20 07:00AM  
Codexis, Inc. discovers, develops, and sells biocatalysts. It offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations. The company's platform is used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. Its platform also enhances the pharmaceuticals companies manufacturing productivity and efficiency or outsourcing the manufacture of the intermediates and active pharmaceutical ingredients. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WOLF DENNIS PDirectorDec 20Sale28.835,000144,15534,925Dec 21 04:28 PM
Yang Patrick YDirectorDec 13Sale31.608,000252,82050,512Dec 14 04:05 PM
NICOLS JOHN JPresident and CEONov 11Option Exercise2.3238,50089,3201,061,179Nov 12 04:21 PM
NICOLS JOHN JPresident and CEONov 11Sale38.4538,5001,480,1951,022,679Nov 12 04:21 PM
NICOLS JOHN JPresident and CEONov 10Option Exercise3.4635,000121,1001,057,679Nov 12 04:21 PM
NICOLS JOHN JPresident and CEONov 10Sale40.2935,0001,410,1391,022,679Nov 12 04:21 PM
Dorgan Byron LDirectorOct 18Sale27.9420,000558,862147,586Oct 19 04:22 PM
WOLF DENNIS PDirectorOct 15Sale28.306,000169,81839,925Oct 18 04:07 PM
NICOLS JOHN JPresident and CEOAug 13Option Exercise3.4635,000121,1001,057,679Aug 16 04:06 PM
NICOLS JOHN JPresident and CEOAug 13Sale23.7735,000831,7961,022,679Aug 16 04:06 PM
NICOLS JOHN JPresident and CEOAug 12Option Exercise3.4635,000121,1001,057,679Aug 16 04:06 PM
NICOLS JOHN JPresident and CEOAug 12Sale24.5335,000858,5461,022,679Aug 16 04:06 PM
KELLEY BERNARD JDirectorAug 10Sale25.8420,000516,820206,136Aug 12 04:13 PM
Yang Patrick YDirectorJun 16Sale20.3120,000406,18658,512Jun 17 04:20 PM
NICOLS JOHN JPresident and CEOMay 18Option Exercise3.4635,000121,1001,057,679May 19 04:11 PM
NICOLS JOHN JPresident and CEOMay 18Sale18.7835,000657,4591,022,679May 19 04:11 PM
NICOLS JOHN JPresident and CEOMay 17Option Exercise3.4635,385122,4321,058,064May 19 04:11 PM
NICOLS JOHN JPresident and CEOMay 17Sale18.1235,385641,3251,022,679May 19 04:11 PM
KELLEY BERNARD JDirectorApr 21Sale22.642,50056,608206,136Apr 22 04:12 PM
Yang Patrick YDirectorApr 05Sale24.2710,000242,73283,716Apr 07 04:48 PM
WOLF DENNIS PDirectorMar 25Sale20.4410,000204,35141,129Mar 29 04:07 PM
KELLEY BERNARD JDirectorMar 08Option Exercise10.5120,000210,200228,636Mar 09 04:20 PM
KELLEY BERNARD JDirectorMar 08Sale18.7220,000374,350208,636Mar 09 04:20 PM